Your browser doesn't support javascript.
loading
Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients.
Agur, Timna; Zingerman, Boris; Ben-Dor, Naomi; Alkeesh, Weaam; Steinmetz, Tali; Rachamimov, Ruth; Korzets, Asher; Rozen-Zvi, Benaya; Herman-Edelstein, Michal.
Afiliação
  • Agur T; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
  • Zingerman B; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ben-Dor N; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
  • Alkeesh W; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Steinmetz T; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
  • Rachamimov R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Korzets A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Rozen-Zvi B; Internal Medicine B, Rabin Medical Center, Hasharon Hospital, Petah-Tikva, Israel.
  • Herman-Edelstein M; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
Nephron ; 147(3-4): 185-192, 2023.
Article em En | MEDLINE | ID: mdl-35896080
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nephron Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nephron Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel